FBS BioProcess
Fetal Bovine Serum (FBS) is necessary for many biopharmaceutical applications. To minimize the contamination risk from animal-derived products, both the FDA and the European counterpart, the EMEA, have released important directives, regulations, and guidelines for the use of bovine sera in biopharmaceutical or diagnostic processes.
General and specific tests for viral contamination and validated inactivation steps have to be carried out in addition for FBS to be used in veterinary medicinal products.
Advantages at a glance
- Tested according to all current biopharmaceutical guidelines for bovine-derived products
- No BVD antibody interferences
- Gentle irradiation at 35 kGy upon request
- Comprehensive documentation on traceability
Applications
- Vaccine production of recombinant monoclonal antibodies
- Manufacturing of monoclonal antibodies
- Production of recombinant growth factors
- Advanced cell therapy
Fetal Bovine Serum (FBS) BioProcess, 9CFR Tested, Origin USA
Fetal Bovine Serum (FBS) BioProcess, 9CFR Tested, Origin USA
Fetal Bovine Serum BioProcess virus tests
|
Viral antibodies |
|
|
BVD-1-AB |
x |
|
BVD-2-AB |
x |
|
Rabies-AB |
x |
|
|
|
|
Viral contaminants |
|
|
Bovine Adeno Virus (BAdV) |
x |
|
Bluetongue Virus (BTV) |
x |
|
Ungulate bocaparvovirus 1, former Bovine Parvovirus (BPV) |
x |
|
Bovine Respiratory Syncytial Virus (BRS-V) |
x |
|
Reovirus (Reo-3) |
x |
|
Bovine Viral Diarrhea Virus (BVD-V) |
x |
|
Rabies Virus |
x |
|
Parainfluenza Virus (Pl-3) |
x |
|
Bovine Herpes Virus (BHV-I/IBR) |
x |
|
|
|
|
Special BVD tests |
|
|
Comparative BVD virus growth inhibition |
x |
|
BVD-AB Interferences |
x |